General Information of the Compound
Compound ID
CP0510114
Compound Name
4-(Benzylamino)quinazoline deriv. 33
    Show/Hide
Structure
Formula
C15H14N4
Molecular Weight
250.305
Canonical SMILES
Nc1ccc2c(NCc3ccccc3)ncnc2c1
    Show/Hide
InChI
InChI=1S/C15H14N4/c16-12-6-7-13-14(8-12)18-10-19-15(13)17-9-11-4-2-1-3-5-11/h1-8,10H,9,16H2,(H,17,18,19)
    Show/Hide
InChIKey
YALFOGLJKIYCIY-UHFFFAOYSA-N
Physicochemical Property
logP
2.8241
Rotatable Bonds
3
Heavy Atom Count
19
Polar Areas
63.83
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
4
Complexity
19

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 5328031
SID: 15391898
ChEMBL ID
CHEMBL330946
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00922, Epidermal growth factor receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000052 A-431 Homo sapiens (Human)  1
1
IC50 > 1000 nM
   TI
   LI
   LO
   TS